TrakCel and Lonza Reach Integration Milestone to Combine Cell and Gene Therapy Manufacturing, Orchestration Solutions

Published on: 

The combined solutions are currently available on the market.

TrakCel announced on March 17, 2023 that their collaboration with Lonza has reached a new milestone, resulting in a secure, reliable combination of TrakCel’s cell orchestration platform OCELLOS and Lonza’s manufacturing MODA-ES(R) platform. This integration will translate into critical manufacturing steps, checks, and data flow directly into the Chain of Custody and Chain of Identity within the cell and gene therapy supply chain without the opportunity of being missed or not connecting with the patient journey.

For developers, this will assist in them gaining additional visibility and control while reducing product loss, delayed treatment, recalls, and poor-quality product. The combined solutions are currently available on the market.


The collaboration between TrakCel and Lonza includes a multi-phase rollout of connectivity with OCELLOS to other Lonza systems like SAP and LIMs. Other integrations are planned to follow the MES proof of concept and are likely to be completed in the second half of 2023.

Source: TrakCel